FDA Import Refusal 523-1312463-9/11/1 — Gemini PharmChem Mannheim GmbH
The FDA refused shipment 523-1312463-9/11/1 from Gemini PharmChem Mannheim GmbH (Germany) on Sep 17, 2021. The refused product falls under Drugs and Biologics — DOXORUBICIN HYDROCHLORIDE (ANTITUMOR). Cited charge: 75 This firm has 1 other import refusal on record.
Refusal Details
- Date
- Sep 17, 2021
- Country
- Germany
- Product Category
- Drugs and Biologics
- Product Code
- 56HCS24 DOXORUBICIN HYDROCHLORIDE (ANTITUMOR)
- Charges
- 75